A single-center, retrospective, observational study of alemtuzumab assessing the efficacy of alemtuzumab in a single-center study under real-life conditions
Latest Information Update: 20 Dec 2021
At a glance
- Drugs Alemtuzumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms REALMS
- 20 Dec 2021 New trial record